HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamide

a MEK1/2 inhibitor; structure in first source
Also Known As:
AS 703026; AS-703026; AS703026; MSC-1236369B; pimasertib
Networked: 36 relevant articles (1 outcomes, 15 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goodstal, Samantha: 4 articles (01/2021 - 01/2015)
2. Massimini, Giorgio: 4 articles (01/2021 - 12/2016)
3. Lesimple, Thierry: 3 articles (01/2021 - 06/2020)
4. Raymond, Eric: 3 articles (01/2021 - 10/2018)
5. Schueler, Armin: 3 articles (01/2021 - 10/2018)
6. Aftimos, Philippe: 2 articles (01/2021 - 01/2021)
7. Awada, Ahmad: 2 articles (01/2021 - 01/2021)
8. Delord, Jean-Pierre: 2 articles (01/2021 - 01/2021)
9. Dinulescu, Monica: 2 articles (01/2021 - 01/2021)
10. Faivre, Sandrine: 2 articles (01/2021 - 01/2021)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Neoplasms (Cancer)
3. Colorectal Neoplasms (Colorectal Cancer)
4. Pancreatic Neoplasms (Pancreatic Cancer)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. Mitogen-Activated Protein Kinase Kinases (MEKs)
2. Everolimus
3. Protein Kinases (Protein Kinase)
4. MK 2206
5. U 0126 (UO 126)
6. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
7. Phosphotransferases (Kinase)
8. XL765
9. AZD 6244
10. Gemcitabine

Related Therapies and Procedures

1. Therapeutics
2. Oral Administration